SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001171843-12-001801
Filing Date
2012-05-10
Accepted
2012-05-10 08:00:45
Documents
2
Effectiveness Date
2012-05-10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS defa14a_051012.htm DEFA14A 26177
2 holliman.jpg GRAPHIC 15974
  Complete submission text file 0001171843-12-001801.txt   49424
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33560 | Film No.: 12827766
SIC: 2834 Pharmaceutical Preparations